Listed by the USPTO as CRUM, MARY ABOU NADER
Tech Center 1600 • Art Units: 1613 1621 1645 1651 1657
This examiner grants 39% of resolved cases
CRUM, MARY ABOU NADER is assigned to USPTO Technology Center 1600 and art unit 1613. The record contains 97 resolved cases, a 39.2% allowance rate, and a 63.7% interview lift. The median time to allowance is 1334 days. The low allowance outcome is paired with a strong interview association, making early issue development and deliberate examiner interviews important elements of prosecution strategy.
The leading companies are Nutricia, Novozymes A/S, and Baxter Healthcare S.A. The leading firms are Ipsilon USA - NLO, Barron & Young PLLC, and CHALKER FLORES, LLP. These participants provide context for the examiner’s biotechnology and healthcare matters.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19305204 | IMMUNOMODULATORY COMPOSITIONS AND METHODS | Final Rejection | Innate Biologics LLC |
| 18291626 | A METHOD AND SYSTEM FOR DETERMINING A QUANTITATIVE COMPOSITION RATIO OF A MICROBIAL STRAIN MIXTURE FOR USE IN A FERMENTATION PROCESS | Final Rejection | DSM IP Assets B.V. |
| 17502595 | SYSTEM AND METHOD FOR BIOREMEDIATION OF SOIL | Final Rejection | The Trustees of Columbia University in the City of New York |
| 18837974 | LACTIC ACID BACTERIUM, LACTIC ACID BACTERIUM COMPOSITION, METHOD FOR PRODUCING LACTIC ACID BACTERIUM, METHOD FOR IMPROVING ACID TOLERANCE OF LACTIC ACID BACTERIUM, METHOD FOR SCREENING LACTIC ACID BACTERIUM, AND METHOD FOR PRODUCING FERMENTED MILK | Non-Final OA | MEIJI CO., LTD. |
| 17283287 | NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE | Non-Final OA | N.V. Nutricia |
| 17283265 | Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection | Final Rejection | N.V. Nutricia |
| 17631943 | COMPOSITION COMPRISING A LIPASE | Non-Final OA | Novozymes A/S |
| 17601019 | Liquid Dishwashing Detergent Compositions | Final Rejection | Novozymes A/S |
| 18562604 | METHOD FOR DETECTING LIVE LACTIC ACID BACTERIA WITH CARBOHYDRATE METABOLISM ACTIVITY | Final Rejection | KABUSHIKI KAISHA YAKULT HONSHA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy39.2% of resolved applications examined by Mary Abou Nader Crum were allowed (97 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +63.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Mary Abou Nader Crum took 1,334 days on average from filing to allowance.
Mary Abou Nader Crum examines applications in Art Unit 1613 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
